The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Dry Powder Inhaler Device Market Research Report 2024

Global Dry Powder Inhaler Device Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1409691

No of Pages : 91

Ask Your Query

Synopsis

A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.

The global Dry Powder Inhaler Device market was valued at US$ 786.6 million in 2023 and is anticipated to reach US$ 1103.8 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.

GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, etc. are the key players in the global Dry Powder Inhaler Device market. Top 4 took up more than 30% of the global market.

From the view of region, USA have a larger consumption market share which account for about 35% of total share. Europe hold a market share of about 25%. In addition, Asia Pacific is also play important role in Global market.

Dry Powder Inhaler Device main application area is Asthma This sector hold a market share of over 80%. Then followed by the COPD.

According to the Segmentation of types, all the market of Dry Powder Inhaler Device can be divided as follows: Multi-dose, Single-dose.

This report aims to provide a comprehensive presentation of the global market for Dry Powder Inhaler Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Powder Inhaler Device.

Report Scope

The Dry Powder Inhaler Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Powder Inhaler Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Dry Powder Inhaler Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • GlaxoSmithKline
  • AstraZeneca
  • Boehringer Ingelheim
  • Chiesi
  • Cipla
  • 3M
  • Hovione
  • Mannkind
  • Mylan
  • Novartis
  • Schering/Merck
  • Teva
  • Vectura

Segment by Type

  • Single Dose
  • Multi Dose

Segment by Application

  • Asthma
  • COPD
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dry Powder Inhaler Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dry Powder Inhaler Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Dry Powder Inhaler Device Market Overview
1.1 Product Overview and Scope of Dry Powder Inhaler Device
1.2 Dry Powder Inhaler Device Segment by Type
1.2.1 Global Dry Powder Inhaler Device Market Value Comparison by Type (2024-2030)
1.2.2 Single Dose
1.2.3 Multi Dose
1.3 Dry Powder Inhaler Device Segment by Application
1.3.1 Global Dry Powder Inhaler Device Market Value by Application: (2024-2030)
1.3.2 Asthma
1.3.3 COPD
1.3.4 Others
1.4 Global Dry Powder Inhaler Device Market Size Estimates and Forecasts
1.4.1 Global Dry Powder Inhaler Device Revenue 2019-2030
1.4.2 Global Dry Powder Inhaler Device Sales 2019-2030
1.4.3 Global Dry Powder Inhaler Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dry Powder Inhaler Device Market Competition by Manufacturers
2.1 Global Dry Powder Inhaler Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dry Powder Inhaler Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dry Powder Inhaler Device Average Price by Manufacturers (2019-2024)
2.4 Global Dry Powder Inhaler Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dry Powder Inhaler Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dry Powder Inhaler Device, Product Type & Application
2.7 Dry Powder Inhaler Device Market Competitive Situation and Trends
2.7.1 Dry Powder Inhaler Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dry Powder Inhaler Device Players Market Share by Revenue
2.7.3 Global Dry Powder Inhaler Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dry Powder Inhaler Device Retrospective Market Scenario by Region
3.1 Global Dry Powder Inhaler Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dry Powder Inhaler Device Global Dry Powder Inhaler Device Sales by Region: 2019-2030
3.2.1 Global Dry Powder Inhaler Device Sales by Region: 2019-2024
3.2.2 Global Dry Powder Inhaler Device Sales by Region: 2025-2030
3.3 Global Dry Powder Inhaler Device Global Dry Powder Inhaler Device Revenue by Region: 2019-2030
3.3.1 Global Dry Powder Inhaler Device Revenue by Region: 2019-2024
3.3.2 Global Dry Powder Inhaler Device Revenue by Region: 2025-2030
3.4 North America Dry Powder Inhaler Device Market Facts & Figures by Country
3.4.1 North America Dry Powder Inhaler Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dry Powder Inhaler Device Sales by Country (2019-2030)
3.4.3 North America Dry Powder Inhaler Device Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dry Powder Inhaler Device Market Facts & Figures by Country
3.5.1 Europe Dry Powder Inhaler Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dry Powder Inhaler Device Sales by Country (2019-2030)
3.5.3 Europe Dry Powder Inhaler Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dry Powder Inhaler Device Market Facts & Figures by Country
3.6.1 Asia Pacific Dry Powder Inhaler Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dry Powder Inhaler Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Dry Powder Inhaler Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dry Powder Inhaler Device Market Facts & Figures by Country
3.7.1 Latin America Dry Powder Inhaler Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dry Powder Inhaler Device Sales by Country (2019-2030)
3.7.3 Latin America Dry Powder Inhaler Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dry Powder Inhaler Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Dry Powder Inhaler Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dry Powder Inhaler Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dry Powder Inhaler Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Dry Powder Inhaler Device Sales by Type (2019-2030)
4.1.1 Global Dry Powder Inhaler Device Sales by Type (2019-2024)
4.1.2 Global Dry Powder Inhaler Device Sales by Type (2025-2030)
4.1.3 Global Dry Powder Inhaler Device Sales Market Share by Type (2019-2030)
4.2 Global Dry Powder Inhaler Device Revenue by Type (2019-2030)
4.2.1 Global Dry Powder Inhaler Device Revenue by Type (2019-2024)
4.2.2 Global Dry Powder Inhaler Device Revenue by Type (2025-2030)
4.2.3 Global Dry Powder Inhaler Device Revenue Market Share by Type (2019-2030)
4.3 Global Dry Powder Inhaler Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dry Powder Inhaler Device Sales by Application (2019-2030)
5.1.1 Global Dry Powder Inhaler Device Sales by Application (2019-2024)
5.1.2 Global Dry Powder Inhaler Device Sales by Application (2025-2030)
5.1.3 Global Dry Powder Inhaler Device Sales Market Share by Application (2019-2030)
5.2 Global Dry Powder Inhaler Device Revenue by Application (2019-2030)
5.2.1 Global Dry Powder Inhaler Device Revenue by Application (2019-2024)
5.2.2 Global Dry Powder Inhaler Device Revenue by Application (2025-2030)
5.2.3 Global Dry Powder Inhaler Device Revenue Market Share by Application (2019-2030)
5.3 Global Dry Powder Inhaler Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline Dry Powder Inhaler Device Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca Dry Powder Inhaler Device Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Dry Powder Inhaler Device Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Chiesi
6.4.1 Chiesi Corporation Information
6.4.2 Chiesi Description and Business Overview
6.4.3 Chiesi Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chiesi Dry Powder Inhaler Device Product Portfolio
6.4.5 Chiesi Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Corporation Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cipla Dry Powder Inhaler Device Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 3M
6.6.1 3M Corporation Information
6.6.2 3M Description and Business Overview
6.6.3 3M Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 3M Dry Powder Inhaler Device Product Portfolio
6.6.5 3M Recent Developments/Updates
6.7 Hovione
6.6.1 Hovione Corporation Information
6.6.2 Hovione Description and Business Overview
6.6.3 Hovione Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hovione Dry Powder Inhaler Device Product Portfolio
6.7.5 Hovione Recent Developments/Updates
6.8 Mannkind
6.8.1 Mannkind Corporation Information
6.8.2 Mannkind Description and Business Overview
6.8.3 Mannkind Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mannkind Dry Powder Inhaler Device Product Portfolio
6.8.5 Mannkind Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Corporation Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mylan Dry Powder Inhaler Device Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novartis Dry Powder Inhaler Device Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Schering/Merck
6.11.1 Schering/Merck Corporation Information
6.11.2 Schering/Merck Dry Powder Inhaler Device Description and Business Overview
6.11.3 Schering/Merck Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Schering/Merck Dry Powder Inhaler Device Product Portfolio
6.11.5 Schering/Merck Recent Developments/Updates
6.12 Teva
6.12.1 Teva Corporation Information
6.12.2 Teva Dry Powder Inhaler Device Description and Business Overview
6.12.3 Teva Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Teva Dry Powder Inhaler Device Product Portfolio
6.12.5 Teva Recent Developments/Updates
6.13 Vectura
6.13.1 Vectura Corporation Information
6.13.2 Vectura Dry Powder Inhaler Device Description and Business Overview
6.13.3 Vectura Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Vectura Dry Powder Inhaler Device Product Portfolio
6.13.5 Vectura Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dry Powder Inhaler Device Industry Chain Analysis
7.2 Dry Powder Inhaler Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dry Powder Inhaler Device Production Mode & Process
7.4 Dry Powder Inhaler Device Sales and Marketing
7.4.1 Dry Powder Inhaler Device Sales Channels
7.4.2 Dry Powder Inhaler Device Distributors
7.5 Dry Powder Inhaler Device Customers
8 Dry Powder Inhaler Device Market Dynamics
8.1 Dry Powder Inhaler Device Industry Trends
8.2 Dry Powder Inhaler Device Market Drivers
8.3 Dry Powder Inhaler Device Market Challenges
8.4 Dry Powder Inhaler Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock